International Medical Device Regulatory Monitor

March 2012 | Vol. 20 No. 3

Device User Fee Hearing Focuses on U.S. FDA Review Times

Lawmakers on both sides of the aisle hammered the U.S. Food and Drug Administration’s (FDA) failure to reduce device approval times, with at least one lawmaker saying he would end the user fee program if “significant reforms” aren’t undertaken.

This article is viewable by subscribers only. To view this article, please select an option below.

Subscribe
Print This Page
RSS
Free Trial
Archives
Sample PDF

Senate Set to Begin Debate on CR Bill, Devices Could Be Major Beneficiary Input Sought on U.S. FDA Device Audit Plan, Assessment Slated for Summer Some Application Goal Dates Delayed Thanks to Hurricane Sandy Closure U.S. FDA Draft Guidance Lays Out Time Clock Strategies for PMAs, 510(k)s

Home
Advertising/Sponsorships
About Us
Contact Us
Site Map
Privacy Policy

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 - Fax (703) 538-7676 - Toll free (888) 838-5578.